台灣癌症登記長表實作指引 (Taiwan Cancer Registry Long Form Implementation Guide)
0.1.1 - ci-build
台灣癌症登記長表實作指引 (Taiwan Cancer Registry Long Form Implementation Guide) - Local Development build (v0.1.1) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Official URL: https://hapi.fhir.tw/fhir/ValueSet/lf-Immu-valueset | Version: 0.1.1 | |||
| Active as of 2024-08-01 | Computable Name: LFImmuVS | |||
Immunotherapy Value Set
References
Generated Narrative: ValueSet lf-Immu-valueset
https://hapi.fhir.tw/fhir/CodeSystem/lf-Immu-codesystem
Generated Narrative: ValueSet
Expansion based on codesystem 申報醫院免疫治療代碼系統 v0.1.1 (CodeSystem)
This value set contains 23 concepts
| Code | System | Display |
| 00 | https://hapi.fhir.tw/fhir/CodeSystem/lf-Immu-codesystem | (1)未接受骨髓/幹細胞移植或內分泌處置，骨髓/幹細胞移植或內分泌處置非首次療程的一部份 (2)由屍體解剖時才診斷為癌症 |
| 01 | https://hapi.fhir.tw/fhir/CodeSystem/lf-Immu-codesystem | 接受全身性免疫藥物治療 |
| 02 | https://hapi.fhir.tw/fhir/CodeSystem/lf-Immu-codesystem | 接受局部性免疫藥物治療 |
| 03 | https://hapi.fhir.tw/fhir/CodeSystem/lf-Immu-codesystem | 接受全身性與局部性免疫藥物治療 |
| 04 | https://hapi.fhir.tw/fhir/CodeSystem/lf-Immu-codesystem | 僅接受免疫細胞治療 |
| 05 | https://hapi.fhir.tw/fhir/CodeSystem/lf-Immu-codesystem | 同時接受免疫細胞治療與全身性免疫藥物治療 |
| 06 | https://hapi.fhir.tw/fhir/CodeSystem/lf-Immu-codesystem | 同時接受免疫細胞治療與局部性免疫藥物治療 |
| 07 | https://hapi.fhir.tw/fhir/CodeSystem/lf-Immu-codesystem | 同時接受免疫細胞治療、全身性與局部性免疫藥物治療 |
| 20 | https://hapi.fhir.tw/fhir/CodeSystem/lf-Immu-codesystem | 僅接受臨床試驗免疫治療 |
| 21 | https://hapi.fhir.tw/fhir/CodeSystem/lf-Immu-codesystem | 同時接受全身性或/與局部性免疫藥物治療及臨床試驗免疫治療 |
| 22 | https://hapi.fhir.tw/fhir/CodeSystem/lf-Immu-codesystem | 同時接受免疫細胞治療及臨床試驗免疫治療 |
| 23 | https://hapi.fhir.tw/fhir/CodeSystem/lf-Immu-codesystem | 同時接受免疫細胞治療與全身性或/與局部性免疫藥物治療及臨床試驗免疫治療 |
| 30 | https://hapi.fhir.tw/fhir/CodeSystem/lf-Immu-codesystem | 僅接受雙盲試驗免疫治療 |
| 31 | https://hapi.fhir.tw/fhir/CodeSystem/lf-Immu-codesystem | 同時接受全身性或/與局部性免疫藥物治療及雙盲試驗免疫治療 |
| 32 | https://hapi.fhir.tw/fhir/CodeSystem/lf-Immu-codesystem | 同時接受免疫細胞治療及雙盲試驗免疫治療 |
| 33 | https://hapi.fhir.tw/fhir/CodeSystem/lf-Immu-codesystem | 同時接受免疫細胞治療與全身性或/與局部性免疫藥物治療及雙盲試驗免疫治療 |
| 82 | https://hapi.fhir.tw/fhir/CodeSystem/lf-Immu-codesystem | 免疫治療因禁忌症或個案其他危險因素(併發症、年邁)而未建議或給予 |
| 83 | https://hapi.fhir.tw/fhir/CodeSystem/lf-Immu-codesystem | 免疫治療因疾病進展而未建議或給予 |
| 85 | https://hapi.fhir.tw/fhir/CodeSystem/lf-Immu-codesystem | 免疫治療是既定之首次療程計畫中的一部分，但因個案未接受治療前即死亡或病危出院 |
| 86 | https://hapi.fhir.tw/fhir/CodeSystem/lf-Immu-codesystem | 免疫治療雖然是既定之首次療程計畫中的一部分，未執行且病歷並未記載未執行的原因；或於他院執行免疫治療 |
| 87 | https://hapi.fhir.tw/fhir/CodeSystem/lf-Immu-codesystem | 免疫治療雖然是既定之首次療程計畫中的一部分，但未執行，且病歷記載個案或其家屬拒絕此項治療 |
| 88 | https://hapi.fhir.tw/fhir/CodeSystem/lf-Immu-codesystem | 免疫治療雖然是既定之首次療程計畫中的一部分，但摘錄時尚未執行 |
| 99 | https://hapi.fhir.tw/fhir/CodeSystem/lf-Immu-codesystem | (1)由於病歷未記載，所以不知道是否骨髓/幹細胞移植或內分泌處置有被建議或是已經執行 (2)僅由死亡證明書得知個案有癌症 |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |